A series of enaminone esters and amides have been developed as potent allosteric modulators of
-aminobutyric acid
A (GABA
A) receptors. The compounds bind to a novel modulatory site that is independentof the benzodiazepine (BZ), isosteric GABA, and neuroactive steroid binding sites. Structure-activityrelationship (SAR) studies resulted in the synthesis of the
c-Bu amide
16h with an in vitro potency of 7 nMbased on inhibition of [
35S]TBPS binding. The activity of the enaminones as positive allosteric modulators
was confirmed
with electrophysiological measurements in oocytes expressing
122L GABA
A receptors.The
i-Pr,
s-Bu,
c-Pr, and
c-Bu amides (
16e-h)
were orally active in mice
with profound central nervoussystem depressant effects. The
i-Pr amide
16e was an orally active anxiolytic in the mouse light-darkparadigm.